CLEC9A and DEC205 CAR Dendritic Cells

Company Suzhou Institute of Systems Medicine (academic) Event Type Peer-reviewed publication (Nature Immunology) Modality CAR-engineered dendritic cells Asset CLEC9A/DEC205 CAR-DC Target Tumor antigens (CAR); CLEC9A; DEC205 signaling Disease Area Solid tumors (preclinical models) Summary A Nature Immunology paper published online November 13 describes engineered dendritic…

🔒

Continue reading this signal

Create a free InSilens account to unlock full articles, analysis, and deal context.

Create Free Account
Share this article :

Leave a Reply

Your email address will not be published. Required fields are marked *